Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018.
Palladini G, Schönland S, Merlini G, Milani P, Jaccard A, Bridoux F, Dimopoulos MA, Ravichandran S, Hegenbart U, Roeloffzen W, Cibeira MT, Agis H, Minnema MC, Bergantim R, Hájek R, João C, Leonidakis A, Cheliotis G, Sonneveld P, Kastritis E, Wechalekar A. Palladini G, et al. Among authors: jaccard a. Blood Cancer J. 2023 Jan 25;13(1):19. doi: 10.1038/s41408-023-00789-8. Blood Cancer J. 2023. PMID: 36697388 Free PMC article.
High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
Jaccard A, Moreau P, Leblond V, Leleu X, Benboubker L, Hermine O, Recher C, Asli B, Lioure B, Royer B, Jardin F, Bridoux F, Grosbois B, Jaubert J, Piette JC, Ronco P, Quet F, Cogne M, Fermand JP; Myélome Autogreffe (MAG) and Intergroupe Francophone du Myélome (IFM) Intergroup. Jaccard A, et al. N Engl J Med. 2007 Sep 13;357(11):1083-93. doi: 10.1056/NEJMoa070484. N Engl J Med. 2007. PMID: 17855669 Free article. Clinical Trial.
Lenalidomide in combination with melphalan and dexamethasone in patients with newly diagnosed AL amyloidosis: a multicenter phase 1/2 dose-escalation study.
Moreau P, Jaccard A, Benboubker L, Royer B, Leleu X, Bridoux F, Salles G, Leblond V, Roussel M, Alakl M, Hermine O, Planche L, Harousseau JL, Fermand JP. Moreau P, et al. Among authors: jaccard a. Blood. 2010 Dec 2;116(23):4777-82. doi: 10.1182/blood-2010-07-294405. Epub 2010 Aug 19. Blood. 2010. PMID: 20724537 Free article. Clinical Trial.
[Current treatment of AL amyloidosis].
Desport E, Moumas E, Abraham J, Delbès S, Lacotte-Thierry L, Touchard G, Fermand JP, Bridoux F, Jaccard A. Desport E, et al. Among authors: jaccard a. Nephrol Ther. 2011 Nov;7(6):467-73. doi: 10.1016/j.nephro.2011.02.003. Epub 2011 Apr 15. Nephrol Ther. 2011. PMID: 21497573 Review. French.
[New insights in the treatment of myeloma with renal failure].
Moumas E, Hanf W, Desport E, Abraham J, Delbès S, Debiais C, Lacotte-Thierry L, Touchard G, Jaccard A, Fermand JP, Bridoux F. Moumas E, et al. Among authors: jaccard a. Nephrol Ther. 2011 Nov;7(6):457-66. doi: 10.1016/j.nephro.2011.03.002. Epub 2011 Apr 23. Nephrol Ther. 2011. PMID: 21515102 Review. French.
Strategies to model AL amyloidosis in mice.
Sirac C, Bender S, Jaccard A, Bridoux F, Lacombe C, Touchard G, Cogné M. Sirac C, et al. Among authors: jaccard a. Amyloid. 2011 Jun;18 Suppl 1:45-7. doi: 10.3109/13506129.2011.574354016. Amyloid. 2011. PMID: 21838428 No abstract available.
260 results